St. Louis, MO – According to filings with the U.S. Securities and Exchange Commission, NewLeaf Symbiotics is raising $35,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Stephen Kahn played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About NewLeaf Symbiotics

NewLeaf Symbiotics has discovered in nature and optimized an important part of the plant’s microbiome. Found on all plants, Methylotrophs, M-trophs are very special micro-organisms with unique features. Over many years of scientific study, development, and trials, NewLeaf has created a technology platform to deliver to farmers natural tools to improve crop yield, protect against insect and disease pressures while improving crop quality and reducing impact on the environment.

To learn more about NewLeaf Symbiotics, visit http://www.newleafsym.com/

Contact:
Stephen Kahn, President and Chief Executive Officer
314-993-4411
skahn@newleafsym.com
https://www.linkedin.com/in/steve-kahn-b605876/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved